# If AbbVie moves, who benefits? How far does the value-chain ripple reach?
Canonical: https://valuechain.wiki/abbvie · Facet: ripple · Updated: 2026-10-09T16:09:06.345+00:00 · Source: ValueChain.wiki (cited money-flow graph)

**Citable summary**: Per the valuechain.wiki graph, AbbVie is directly linked to 4 companies (1 supply, 3 revenue relationships) and reaches 5 companies within two hops; the links are backed by 10 dated sources, 5 of them primary filings (as of 2026-10-09).

AbbVie operates across S&P 500, Pharma, Skyrizi & Rinvoq (post-Humira). It is +14.9% in 2026. The stock (+14.9%) and its demand side (avg -5.9%) are moving in step. Neuroscience (Vraylar, Botox), oncology (Imbruvica, Venclexta) and aesthetics round out the mix.

## Demand chain (leading)
- T1 Celltrion (https://valuechain.wiki/celltrion.md)
- T1 Cencora, Inc. (https://valuechain.wiki/cencora.md)
- T1 Cardinal Health, Inc. (https://valuechain.wiki/cardinal-health.md)
- T2 CVS Health (https://valuechain.wiki/cvs-health.md)
- T3 Elevance Health, Inc. (https://valuechain.wiki/elevance-health.md)

## Supply chain (benefiting)
- T1 AbCellera Biologics (https://valuechain.wiki/abcellera.md)

---
Full node: https://valuechain.wiki/abbvie.md · JSON: https://valuechain.wiki/abbvie.json